Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Women’s health

NICE publishes first guideline on endometriosis

The first national guideline aiming to speed up the diagnosis, treatment and management of women with endometriosis has been published by the National Institute for Health and Care Excellence (NICE).

Women can face a seven-and-a-half-year wait, on average, for a confirmed diagnosis of endometriosis — a chronic condition in which cells usually found in the womb grow elsewhere in the body, triggering painful and heavy periods, bladder and bowel problems and reduced fertility.

Professor Mark Baker, director of the centre for guidelines at NICE, England’s health technology assessment body, said: “This guideline will help healthcare professionals detect endometriosis early, to close the symptom-to-diagnosis gap and to ensure more timely treatment.”

The guideline includes a list of symptoms that doctors and other healthcare professionals should look for – such as pelvic pain and painful periods – which it hopes will help reduce delays in beginning treatment.

Healthcare professionals should also be aware that the condition can be long-term and have a “significant impact” on a patient’s sex life and physical and mental health.

The guideline recommends that if symptoms persist, regardless of initial examination or investigation, the woman should be referred for further assessment.

Emma Cox, chief executive of the patient support charity Endometriosis UK, said the guideline will “raise the bar” in endometriosis care by setting standards of care and increasing healthcare professionals’ knowledge and skills.

Caroline Overton, consultant gynaecologist and chair of the NICE guideline committee said it is “imperative” that women are given support to manage their symptoms as the condition is incurable: “This guideline highlights the different programmes of care available to help reduce the burden of this disease on women’s lives. As one of the most common gynaecological diseases in the UK, it is vital that endometriosis is more widely recognised now.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203518

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.